Morufat Oluwatosin Olaitan

Morufat Oluwatosin Olaitan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2025 in One Health
Verified
Journal Article
Open access
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
OOOluwatosin Qawiyy Orababa
Oluwatosin Qawiyy Orababa
RSRukayya Bushola Shittu
Rukayya Bushola Shittu
GOGift Maureen Obunukwu
Gift Maureen Obunukwu
AKAyomikun Emmanuel Kade
Ayomikun Emmanuel Kade
RYRildwan Alaba Yusuff
Rildwan Alaba Yusuff
The rise in the prevalence of antimicrobial-resistant (AMR) pathogens globally has been a major concern, especially due to the increasing mortality associated with AMR. One of these pathogens -classified as a WHO priority pathogen- is extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. In this study, we aim to determine the prevalence of ESBL-producing E. coli in sub-Saharan Africa (SSA) as well as the genes responsible for its spread in the region. Based on the PRISMA guideline, we screened 6521 articles published between 2013 and 2023 from PubMed, AJOL, Google Scholar, Scopus, and Web of Science using pre-set eligibility criteria. The final meta-analysis included one hundred and ninety-six of these articles. In this study, we reported an overall ESBL-producing E. coli prevalence of 20.76 % in SSA. Subregion analysis showed that West Africa had the highest prevalence of 22.80 % while Southern Africa (13.76 %) has the lowest ESBL-producing E. coli prevalence in SSA. Among the countries in SSA, Burkina Faso (33.37 %) had the highest prevalence of ESBL-producing E. coli. Additionally, sample source subgroup analysis revealed animals as the highest source of ESBL-producing E. coli in SSA with a prevalence of 29.15 %. We also found that bla CTX-M-15 is the most reported ESBL gene in E. coli in SSA. Our study shows a high prevalence of ESBL-producing E. coli in SSA countries, with animals significantly contributing to the spread of ESBL resistance in the region compared to humans, the environment and food. This study further emphasizes the importance of an interdisciplinary and intergovernmental approach to reducing AMR spread in SSA. Additionally, we implore policymakers to implement policies that will encourage responsible use of antimicrobials in both the clinic and agriculture to prevent the widespread of AMR genes.

28 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MAMargaret Toluwalayo Arowolo
Margaret Toluwalayo Arowolo
OOOluwatosin Qawiyy Orababa
Oluwatosin Qawiyy Orababa
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
BOBisola Victoria Osibeluwo
Bisola Victoria Osibeluwo
UEUtibeima Udo Essiet
Utibeima Udo Essiet
EOElizabeth Olumodeji
Elizabeth Olumodeji
Carbapenems are effective drugs against bacterial pathogens and resistance to them is considered a great public health threat, especially in notorious nosocomial pathogens like Acinetobacter baumannii and Pseudomonas aeruginosa. In this study, we aimed to determine the prevalence of carbapenem resistance in A. baumannii and P. aeruginosa infections in Sub-Saharan Africa. Databases (PubMed, Scopus, Web of Science, and African Journal Online) were systematically searched following the Preferred Reporting Items for Systematic review and meta-analysis protocols (PRISMA-P) 2020 statements for articles reporting carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) prevalence between 2012 and 2022. Pooled prevalence was determined with the random effect model and funnel plots were used to determine heterogeneity in R. A total of 47 articles were scanned for eligibility, among which 25 (14 for carbapenem-resistant A. baumannii and 11 for carbapenem-resistant P. aeruginosa) were included in the study after fulfilling the eligibility criteria. The pooled prevalence of CRPA in the present study was estimated at 8% (95% CI; 0.02–0.17; I2 = 98%; P <0.01). There was high heterogeneity (Q = 591.71, I2 = 98.9%; P<0.0001). In addition, this study’s pooled prevalence of CRAB was estimated at 20% (95% CI; 0.04–0.43; I2 = 99%; P <0.01). There was high heterogeneity (Q = 1452.57, I2 = 99%; P<0.0001). Also, a funnel plot analysis of the studies showed high degree of heterogeneity. The carbapenemase genes commonly isolated from A. baumannii in this study include blaOXA23, blaOXA48, blaGES., blaNDM, blaVIM, blaOXA24, blaOXA58, blaOXA51, blaSIM-1, blaOXA40, blaOXA66, blaOXA69, blaOXA91, with blaOXA23 and blaVIM being the most common. On the other hand, blaNDM, blaVIM, blaIMP, blaOXA48, blaOXA51, blaSIM-1, blaOXA181, blaKPC, blaOXA23, blaOXA50 were the commonly isolated carbapenemase genes in P. aeruginosa, among which blaVIM and blaNDM genes were the most frequently isolated. Surveillance of drug-resistant pathogens in Sub-Saharan Africa is essential in reducing the region’s disease burden. This study has shown that the region has significantly high multidrug-resistant pathogen prevalence. This is a wake-up call for policymakers to put in place measures to reduce the spread of these critical priority pathogens.

1 July 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
OOOluwatosin Qawiyy Orababa
Oluwatosin Qawiyy Orababa
RSRukayya Bushola Shittu
Rukayya Bushola Shittu
AOAdams Alabi Oyediran
Adams Alabi Oyediran
GOGift Maureen Obunukwu
Gift Maureen Obunukwu
RYRildwan Alaba Yusuff
Rildwan Alaba Yusuff
Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae is a critical priority pathogen for which there is a need for new antimicrobials and poses a great public health threat to many parts of the world including sub-Saharan Africa (SSA). This study aims to determine the prevalence of ESBL-producing K. pneumoniae in SSA using a one health perspective, and the predominant ESBL genes in the region. Databases such as PubMed, Scopus, Web of Science, Africa Journal Online, and Google Scholar were searched for eligible articles based on pre-set eligibility criteria. After screening of titles, abstracts, and full texts, a meta-analysis using a random-effect model was conducted on the eligible studies to determine the overall and subgroup prevalence of ESBL-producing K. pneumoniae in SSA. This meta-analysis included 119 eligible studies from 25 SSA countries in all SSA subregions. The overall prevalence of ESBL-producing K. pneumoniae in SSA is estimated to be 8.6% [95% CI: 6.4–11]. South Africa (18.5%) and Central Africa (4.6%) subregions have the highest and lowest prevalence of ESBL-producing K. pneumoniae in the region, respectively. Additionally, South Africa (23.3%), Kenya (23%), and Nigeria (11.1%) are the top three countries with ESBL-K. pneumoniae. Animal samples were also seen to have the highest prevalence compared to clinical and environmental samples in this study. Lastly, blaCTX−M−15 was the most reported ESBL gene in SSA. The widespread presence of resistant strains in certain regions poses a significant risk of inter-country transmission, highlighting the need for collaborative regional surveillance and control efforts.

15 December 2022 in International Journal of Traditional and Complementary Medicine Research
Verified
Journal Article
Open access
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
BNBlessing Nwadi̇kE
Blessing Nwadi̇kE
Objective: Majority of the current antibiotics have become less effective due to widespread of multidrug-resistant microorganisms. Medicinal plants are promising candidates that could be used to manage this menace. Therefore, phytochemical, toxicological and antimicrobial potentiality of Lawsonia inermis extracts against MDR clinical bacteria were carried out. Material-Method: Henna leaf and seed were extracted by cold maceration technique using methanol and water and screened phytochemically. Eight MDR isolates, four of which are ESβL-producers were used for this study. In vitro antimicrobial efficacy and quantitative antimicrobial potency of extracts were estimated. MIC and MBC were determined using broth macrodilution technique. Cytotoxicity test was conducted using brine shrimp lethality assay and LC50 was determined. Results: The findings of this study revealed that aqueous leaf extract possesses maximum percentage yield of 25.58%. Tannins and phenolic compounds were detected in all extracts, while steroid was absent. Methanol seed extract showed the highest antimicrobial efficacy against all bacteria with 100 percent activity. The highest and lowest zones of inhibition were recorded at 30.0±0.00 and 10.0±0.00 mm, respectively. The zones of inhibition of extracts differed significantly. All extracts displayed highest activity index against the ESβL-producing Enterobacter aerogenes 196 that was isolated from wound with highest value at 4.28. Pseudomonas aeruginosa U109 showed maximum susceptibility index (93.75%); majority of MIC values recorded were within the range of 1.95-62.5 mg/mL. Cytotoxicity test of methanol and aqueous extracts displayed 10001000, respectively. Conclusion: Findings from this study elucidate the efficacy of Lawsonia inermis as a potential remedy to manage MDR-related infectious bacteria.

29 January 2026 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
ARAkeem Ganiyu Rabiu
Akeem Ganiyu Rabiu
AAAbimbola Olumide Adekanmbi
Abimbola Olumide Adekanmbi
AMAbidemi Joseph Marcus
Abidemi Joseph Marcus
SBSheriffdeen Issa Bale
Sheriffdeen Issa Bale
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
OFOlutayo Israel Falodun
Olutayo Israel Falodun

11 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MOMorufat Oluwatosin Olaitan
Morufat Oluwatosin Olaitan
OOOluwatosin Qawiyy Orababa
Oluwatosin Qawiyy Orababa
BSBushola Rukayya Shittu
Bushola Rukayya Shittu
AOAdams Alabi Oyediran
Adams Alabi Oyediran
GOGift Maureen Obunukwu
Gift Maureen Obunukwu
RYRildwan Alaba Yusuff
Rildwan Alaba Yusuff
Summary: Background: Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae is a critical priority pathogen for which there is a need for new antimicrobials and poses a great public health threat to many parts of the world including sub-Saharan Africa (SSA). This study aims to determine the prevalence of ESBL-resistant K. pneumoniae in SSA and the predominant ESBL genes in the region. Methods: Databases such as PubMed, Scopus, Web of Science, Africa Journal Online, and Google Scholar were searched for eligible articles based on preset eligibility criteria. After screening of titles, abstracts, and full texts, a meta-analysis using a random-effect model was conducted on the eligible studies to determine the overall and subgroup prevalence of ESBL-producing K. pneumoniae in SSA. Findings: This meta-analysis included 119 eligible studies from 25 SSA countries in all SSA subregions. The overall prevalence of ESBL-resistant K. pneumoniae in SSA is estimated to be 8·6% [95% CI: 6·4-11]. South Africa (18·5%) and Central Africa (4·6%) subregions have the highest and lowest prevalence of ESBL-producing K. pneumoniae in the region, respectively. Additionally, South Africa (23·3%), Kenya (23%), and Nigeria (11·1%) are countries with the top three prevalence of ESBL-resistant K. pneumoniae in the region. Animal samples were also seen to have the highest prevalence compared to clinical and environmental samples in this study. Lastly, CTX-M-15 was the most reported ESBL gene in SSA. Interpretation: Although this study reports a low pooled prevalence of ESBL-resistant K. pneumoniae in SSA, some countries in the region have a high burden of this drug-resistant strain. Additionally, some countries in the region lack data on this drug-resistant strain, thus putting other parts of the region at risk due to the porous borders and immigration between the countries in the region. Funding: There was no funding for this study